NCT04033315

Brief Summary

L-PLUS (Lightning PLUS) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and marketed CONTOUR PLUS® test strip. This clinical trial will assess the performance (accuracy) of the L-PLUS meter by lay users with diabetes enrolled as subjects in the study, and by health care professionals (also called study staff). The trial will follow the requirements and procedures described in ISO 15197:2013 International Standard.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2019

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2019

Completed
4.8 years until next milestone

Results Posted

Study results publicly available

June 13, 2024

Completed
Last Updated

June 13, 2024

Status Verified

May 1, 2024

Enrollment Period

2 months

First QC Date

July 24, 2019

Results QC Date

March 27, 2024

Last Update Submit

May 17, 2024

Conditions

Keywords

diabetesBGMSblood glucose monitoring systemfingerstickAST self-testYSI Glucose Analyzer

Outcome Measures

Primary Outcomes (1)

  • Accuracy of BGMS Compared to the Reference Analyzer - Fingerstick Blood Test

    Accuracy of BGMS test with fingerstick blood. The results of the fingerstick meter test performed by the participant will be compared to results of the same blood on a laboratory reference analyzer using pre-specified accuracy criteria.

    Day 1

Secondary Outcomes (2)

  • Accuracy of BGMS Compared to the Reference Analyzer - Palm Alternative Site Test (AST)

    Day 1

  • Accuracy of BGMS Compared to the Reference Analyzer - Venous Blood

    Day 1

Study Arms (1)

Untrained Subjects with Diabetes use the L-PLUS BGMS

EXPERIMENTAL

Untrained subjects with Diabetes test capillary fingerstick and palm blood (and study staff test subject fingerstick blood) using the L-PLUS BGMS. All blood glucose results are compared to reference method results obtained with subject capillary plasma. Also, study staff test venous blood and blood glucose results are compared to reference method results obtained from subject venous plasma.

Device: L-PLUS meter

Interventions

Blood Glucose Monitoring System

Untrained Subjects with Diabetes use the L-PLUS BGMS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females, 18 years of age and older
  • People with diabetes (PWD) - type 1 or type 2
  • Ability to speak, read and understand English. Subjects must demonstrate ability to read a paragraph from the first page of the UG to qualify for the study.
  • Willing to complete all study procedures

You may not qualify if:

  • Hemophilia or any other bleeding disorder
  • Pregnancy (self-reported)
  • Physical, visual or neurological impairments that would make the person unable to perform testing with the BGMS.
  • Previous participation in a blood glucose monitoring study using the Ascensia's Contour Next (Lightning Next) and Lightning PLUS (L-PLUS or Contour Plus ELITE) BGMS.
  • Working for a medical laboratory, hospital or other clinical setting that involves training on or clinical use of blood glucose monitors.
  • Being in this trial during or less than two days since xylose absorption testing (Xylose in the blood is known to cause interference).
  • Working for a competitive medical device company, or having an immediate family member or someone who is not a family member but is living within the household of someone who works for such a company.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rainier Clinical Research Center, Inc.

Renton, Washington, 98057, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Jane Wallace
Organization
Ascensia Diabetes Care

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: All subjects will be assigned to use the L-PLUS meter
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2019

First Posted

July 26, 2019

Study Start

July 15, 2019

Primary Completion

September 5, 2019

Study Completion

September 5, 2019

Last Updated

June 13, 2024

Results First Posted

June 13, 2024

Record last verified: 2024-05

Locations